Davis Polk advised the joint book-running managers, J.P. Morgan Securities LLC and Jefferie, in the offering.Deciphera Pharmaceuticals, Inc. executed a $172.5 million SEC-registered common stock and pre-funded…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Laura Testa
…
This content is for Standard 1 Year members only. LoginJoin Now